by Laura Smith | Aug 9, 2022 | Communications, Journal Club
Discussion around the effects of a cannabinoid receptor 1 antagonist on THC-induced vascular inflammation Please join us for a conversation about a study published in 2022 in the Journal Cell entitled: “Cannabinoid receptor 1 antagonist genistein...by Laura Smith | Aug 8, 2022 | Communications, Journal Club
Discussion around survey results behind cannabis use during pregnancy Please join us for a conversation about a study published in 2022 in the Journal of Cannabis Research entitled: “Factors that shape pregnant women’s perceptions regarding the safety of cannabis use...by Laura Smith | Aug 8, 2022 | Communications, Journal Club
Discussion around the anti-COVID-19 potential of different cannabis extracts in reducing inflammation Please join us for a conversation about a study published in 2022 in the journal Cell Death Discovery entitled: “New AKT-dependent mechanisms of anti-COVID-19 action...by Laura Smith | Aug 5, 2022 | Communications, Weekly Cannabis News
Weekly Cannabis News July 29th – August 5th, 2022 Cannabis Use to Treat Perimenopause and Postmenopause Symptoms: Results from Survey 86.1% of participants reported using cannabis, with 78.7% to treat menopausal-related symptoms. There are 3 types of menopauses...by Laura Smith | Aug 3, 2022 | Communications
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default”...by Laura Smith | Aug 3, 2022 | Communications
[vc_row type=”in_container” full_screen_row_position=”middle” column_margin=”default” column_direction=”default” column_direction_tablet=”default” column_direction_phone=”default”...